TY - JOUR
T1 - Haemangiomas in kidneys with end-stage renal disease
T2 - A novel clinicopathological association
AU - Kryvenko, Oleksandr N.
AU - Haley, Susan L.
AU - Smith, Steven C.
AU - Shen, Steven S.
AU - Paluru, Swetha
AU - Gupta, Nilesh S.
AU - Jorda, Merce
AU - Epstein, Jonathan I.
AU - Amin, Mahul B.
AU - Truong, Luan D.
PY - 2014
Y1 - 2014
N2 - Aims: The study of haemangiomas in end-stage renal disease (ESRD). Methods and results: Twenty ESRD nephrectomies from 16 patients (aged 9 months-68 years) were due to hypertension (four), focal segmental glomerulosclerosis (four), lupus nephritis (three), diabetes (one), IgA nephropathy (one), hereditary nephritis (one), congenital nephrotic syndrome (one) and unknown cause (one). Haemangiomas appeared as a single mass (15), two masses (one), three masses (one), four masses (two) and eight masses (one) per kidney. Tumours measured 0.2-3.5 cm. Four patients had bilateral haemangiomas. All tumours were in the medulla and often abutted renal sinus fat. All except one of the tumours were anastomosing haemangiomas, showing isolated or interconnected sinusoidal capillary-sized vascular channels lined by a single layer of benign cuboidal CD34+, CD31+, D2-40- endothelial cells, separated by loose stroma with spindle cells. One tumour was a cellular capillary haemangioma. Intravascular growth was seen in nine specimens. All haemangiomas had extramedullary haematopoiesis. Acquired cystic kidney disease (ACKD) was seen in 11 kidneys (nine patients), renal cell carcinoma (RCC) in five, ACKD-associated RCC precursors in three, Wilms' tumour in one and papillary adenomas in five. Conclusions: Anastomosing haemangioma appears as a distinctive clinicopathological entity developing in kidneys with ESRD, with or without ACKD.
AB - Aims: The study of haemangiomas in end-stage renal disease (ESRD). Methods and results: Twenty ESRD nephrectomies from 16 patients (aged 9 months-68 years) were due to hypertension (four), focal segmental glomerulosclerosis (four), lupus nephritis (three), diabetes (one), IgA nephropathy (one), hereditary nephritis (one), congenital nephrotic syndrome (one) and unknown cause (one). Haemangiomas appeared as a single mass (15), two masses (one), three masses (one), four masses (two) and eight masses (one) per kidney. Tumours measured 0.2-3.5 cm. Four patients had bilateral haemangiomas. All tumours were in the medulla and often abutted renal sinus fat. All except one of the tumours were anastomosing haemangiomas, showing isolated or interconnected sinusoidal capillary-sized vascular channels lined by a single layer of benign cuboidal CD34+, CD31+, D2-40- endothelial cells, separated by loose stroma with spindle cells. One tumour was a cellular capillary haemangioma. Intravascular growth was seen in nine specimens. All haemangiomas had extramedullary haematopoiesis. Acquired cystic kidney disease (ACKD) was seen in 11 kidneys (nine patients), renal cell carcinoma (RCC) in five, ACKD-associated RCC precursors in three, Wilms' tumour in one and papillary adenomas in five. Conclusions: Anastomosing haemangioma appears as a distinctive clinicopathological entity developing in kidneys with ESRD, with or without ACKD.
KW - End-stage renal disease
KW - Haemangioma
KW - Kidney
UR - http://www.scopus.com/inward/record.url?scp=84927577439&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84927577439&partnerID=8YFLogxK
U2 - 10.1111/his.12394
DO - 10.1111/his.12394
M3 - Article
C2 - 24548339
AN - SCOPUS:84927577439
SN - 0309-0167
VL - 65
SP - 309
EP - 318
JO - Histopathology
JF - Histopathology
IS - 3
ER -